Global burden of cancers attributable to infections in 2012: a synthetic analysis.

[1]  M. Plummer,et al.  Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa , 2016, Journal of acquired immune deficiency syndromes.

[2]  Hai-rim Shin,et al.  Prevention of infection-related cancers in the WHO Western Pacific Region. , 2016, Japanese journal of clinical oncology.

[3]  J. Horng,et al.  Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan. , 2015, Journal of hepatology.

[4]  M. Plummer,et al.  Cancers attributable to infections among adults with HIV in the United States , 2015, AIDS.

[5]  M. Plummer,et al.  World‐wide relative contribution of hepatitis B and C viruses in hepatocellular carcinoma , 2015, Hepatology.

[6]  L. Eckert,et al.  Gavi HPV Programs: Application to Implementation , 2015, Vaccines.

[7]  M. Bower,et al.  Facing up to the ongoing challenge of Kaposi's sarcoma , 2015, Current opinion in infectious diseases.

[8]  M. Plummer,et al.  Global burden of gastric cancer attributable to Helicobacter pylori , 2015, International journal of cancer.

[9]  Selim Jahan,et al.  Human development report 2015: work for human development , 2015 .

[10]  D. Forman,et al.  The fight against gastric cancer - the IARC Working Group report. , 2014, Best practice & research. Clinical gastroenterology.

[11]  M. Egger,et al.  Kaposi's Sarcoma in HIV‐infected patients in South Africa: Multicohort study in the antiretroviral therapy era , 2014, International journal of cancer.

[12]  S. Sanjosé,et al.  HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. , 2014, The Lancet. Oncology.

[13]  Ju-Han Lee,et al.  Prevalence and prognostic significance of Epstein-Barr virus infection in classical Hodgkin's lymphoma: a meta-analysis. , 2014, Archives of medical research.

[14]  S. Franceschi,et al.  Role of human papillomavirus in non-oropharyngeal head and neck cancers. , 2014, Oral oncology.

[15]  M. Buti,et al.  Historical epidemiology of hepatitis C virus (HCV) in selected countries , 2014, Journal of viral hepatitis.

[16]  D. Holtzman,et al.  Previous exposure to HCV among persons born during 1945-1965: prevalence and predictors, United States, 1999-2008. , 2014, American journal of public health.

[17]  Henry C Kitchener,et al.  Human papillomavirus and cervical cancer , 2013, The Lancet.

[18]  K. Malik,et al.  Human Development Report 2013. The Rise of the South: Human Progress in a Diverse World , 2013 .

[19]  A. Hall,et al.  Evaluation of data quality at the Gambia national cancer registry , 2013, International journal of cancer.

[20]  Jacques Ferlay,et al.  GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC Cancer Base No. 11 [Internet] , 2013 .

[21]  A. Jemal,et al.  Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. , 2012, The Lancet. Oncology.

[22]  Jacques Ferlay,et al.  The global burden of cancers attributable to infections in the year 2008: a review and synthetic analysis Web appendix section , 2012 .

[23]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[24]  Who Publication.  Hepatitis B vaccines: WHO position paper--recommendations. , 2010, Vaccine.

[25]  humAn cArcinogens,et al.  [Biological agents]. , 2009, Nihon rinsho. Japanese journal of clinical medicine.

[26]  D. Parkin,et al.  The global health burden of infection‐associated cancers in the year 2002 , 2006, International journal of cancer.

[27]  Christian P. Robert,et al.  Monte Carlo Statistical Methods , 2005, Springer Texts in Statistics.

[28]  J. Ferlay,et al.  Cancer and infection: estimates of the attributable fraction in 1990. , 1997, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.